The results demonstrated that GAL can be used as a therapeutic target to reduce DOX-induced cognitive deficits by enhancing cholinergic transmission, inhibiting proinflammatory cytokine release, and enhancing cognitive ability. Here, GAL is linked to Cognitive impairment.